Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - INNOVUS PHARMACEUTICALS, INC. | v336896_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - INNOVUS PHARMACEUTICALS, INC. | v336896_ex31-1.htm |
| EX-10.5 - EXHIBIT 10.5 - INNOVUS PHARMACEUTICALS, INC. | v336896_ex10-5.htm |
| EX-10.4 - EXHIBIT 10.4 - INNOVUS PHARMACEUTICALS, INC. | v336896_ex10-4.htm |
| EX-21.1 - EXHIBIT 21.1 - INNOVUS PHARMACEUTICALS, INC. | v336896_ex21-1.htm |
| EX-10.2B - EXHIBIT 10.2B - INNOVUS PHARMACEUTICALS, INC. | v336896_ex10-2b.htm |
| EX-10.2A - EXHIBIT 10.2A - INNOVUS PHARMACEUTICALS, INC. | v336896_ex10-2a.htm |
| EX-10.3B - EXHIBIT 10.3B - INNOVUS PHARMACEUTICALS, INC. | v336896_ex10-3b.htm |
| EX-10.11A - EXHIBIT 10.11A - INNOVUS PHARMACEUTICALS, INC. | v336896_ex10-11a.htm |
| EX-10.11B - EXHIBIT 11B - INNOVUS PHARMACEUTICALS, INC. | v336896_ex10-11b.htm |
| 10-K - FORM 10-K - INNOVUS PHARMACEUTICALS, INC. | v336896_10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement of Innovus Pharmaceuticals, Inc. (the “Company”) on Form S-8 (No. 333-186725-13620840), pertaining to the Company’s Incentive Stock Option Plan, Nonstatutory Stock Option Agreement, and the Company’s Equity Incentive Plan, of our report dated March 19, 2013, on our audits of the consolidated financial statements as of December 31, 2012 and 2011 and for the period from inception (October 31, 2008) to December 31, 2012, which report is included in the Annual Report on Form 10-K filed on March 19, 2013. Our report includes an emphasis-of-matter paragraph highlighting the funding commitment from the President and Chief Executive Office of the Company.
/s/ Eisner Amper LLP
Edison, New Jersey
March 19, 2013